We analyzed the proteomic profiles of patients with CHB, LC, and HCC and HCs using sEVs and identified five biomarkers, namely CO9, LBP, SVEP1, VWF, and KV311. The gene discussed is LBP; the disease is laryngotracheoesophageal cleft.